PlainRecalls
FDA Devices Moderate Class II Ongoing

Alinity m HBV AMP Kit (US and CE)

Reported: April 13, 2022 Initiated: March 4, 2022 #Z-0884-2022

Product Description

Alinity m HBV AMP Kit (US and CE)

Reason for Recall

There is a potential for misquantitation high results for negative samples.

Details

Recalling Firm
Abbott Molecular, Inc.
Units Affected
4966 kits, updated 101/17/2023
Distribution
US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam
Location
Des Plaines, IL

Frequently Asked Questions

What product was recalled?
Alinity m HBV AMP Kit (US and CE). Recalled by Abbott Molecular, Inc.. Units affected: 4966 kits, updated 101/17/2023.
Why was this product recalled?
There is a potential for misquantitation high results for negative samples.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 13, 2022. Severity: Moderate. Recall number: Z-0884-2022.